Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Cholankeril

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Hepatology (Baltimore, Md.)|June 24, 2021
NAFLD and HCC: Time to Bridge the GapGeorge Cholankeril, Fasiha Kanwal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2017
Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United StatesGeorge Cholankeril, Aijaz Ahmed
Journal of Hepatology|February 3, 2024
Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea"George Cholankeril, Fasiha Kanwal
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2024
Unseen foe: The financial toxicity of liver transplantationGeorge Cholankeril, Fasiha Kanwal
Hepatology (Baltimore, Md.)|September 18, 2023
The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!George Cholankeril, John M Vierling
Current Opinion in Infectious Diseases|September 15, 2021
Gastrointestinal manifestations of coronavirus disease 2019Tejas Joshi, Aijaz Ahmed, George Cholankeril
Journal of Obesity & Metabolic Syndrome|October 20, 2024
Association between Body Fat Distribution and Nonalcoholic Fatty Liver Disease/Fibrosis Based on Race/EthnicityDonghee Kim, George Cholankeril, Aijaz Ahmed
Seminars in Liver Disease|October 10, 2022
Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseGeorge Cholankeril, Hashem B El-Serag
Hepatology (Baltimore, Md.)|September 23, 2024
Beyond the baseline: Longitudinal surveillance with noninvasive tests for fibrosis in MASLDVinh V Tran, Fasiha Kanwal, George Cholankeril
Clinical Liver Disease|April 1, 2020
Treating Alcohol Use Disorder in Chronic Liver DiseaseEric R Yoo, George Cholankeril, Aijaz Ahmed
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|June 24, 2021
NAFLD and HCC: Time to Bridge the GapGeorge Cholankeril, Fasiha Kanwal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2017
Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United StatesGeorge Cholankeril, Aijaz Ahmed
Journal of Hepatology|February 3, 2024
Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea"George Cholankeril, Fasiha Kanwal
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2024
Unseen foe: The financial toxicity of liver transplantationGeorge Cholankeril, Fasiha Kanwal
Hepatology (Baltimore, Md.)|September 18, 2023
The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!George Cholankeril, John M Vierling
Current Opinion in Infectious Diseases|September 15, 2021
Gastrointestinal manifestations of coronavirus disease 2019Tejas Joshi, Aijaz Ahmed, George Cholankeril
Journal of Obesity & Metabolic Syndrome|October 20, 2024
Association between Body Fat Distribution and Nonalcoholic Fatty Liver Disease/Fibrosis Based on Race/EthnicityDonghee Kim, George Cholankeril, Aijaz Ahmed
Seminars in Liver Disease|October 10, 2022
Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseGeorge Cholankeril, Hashem B El-Serag
Hepatology (Baltimore, Md.)|September 23, 2024
Beyond the baseline: Longitudinal surveillance with noninvasive tests for fibrosis in MASLDVinh V Tran, Fasiha Kanwal, George Cholankeril
Clinical Liver Disease|April 1, 2020
Treating Alcohol Use Disorder in Chronic Liver DiseaseEric R Yoo, George Cholankeril, Aijaz Ahmed
Pageof 20